Repare Therapeutics Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Repare Therapeutics Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$43.53 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-11-14
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $3.26M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$16.74M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$30.04M, a 328.26% decline year-over-year.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$28.67M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$84.69M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$93.80M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$29.05M.
- Repare Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$106.91M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-09-30 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$13.49M derived: sum of 2 quarters · filed 2025-11-14 | -$43.53M 10-Q · filed 2025-11-14 | -$72.20M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$16.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$46.79M 10-Q · filed 2025-08-08 | -$75.46M derived: sum of 3 quarters · filed 2025-08-08 | -$109.86M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$30.04M 10-Q · filed 2025-05-13 | -$58.71M derived: sum of 2 quarters · filed 2025-05-13 | -$93.12M derived: sum of 3 quarters · filed 2025-11-14 | -$127.89M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$28.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$63.08M derived: sum of 2 quarters · filed 2025-11-14 | -$97.85M derived: sum of 3 quarters · filed 2025-11-14 | -$84.69M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$34.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$69.18M derived: sum of 2 quarters · filed 2025-11-14 | -$56.02M 10-Q · filed 2025-11-14 | -$84.05M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$34.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$21.61M 10-Q · filed 2025-08-08 | -$49.64M derived: sum of 3 quarters · filed 2025-08-08 | -$68.52M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $13.16M 10-Q · filed 2025-05-13 | -$14.87M derived: sum of 2 quarters · filed 2025-05-13 | -$33.75M derived: sum of 3 quarters · filed 2025-05-13 | -$45.69M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$28.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$46.91M derived: sum of 2 quarters · filed 2025-03-03 | -$58.85M derived: sum of 3 quarters · filed 2025-03-03 | -$93.80M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$18.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$30.82M derived: sum of 2 quarters · filed 2024-11-07 | -$65.77M 10-Q · filed 2024-11-07 | -$97.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$11.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$46.89M 10-Q · filed 2024-08-06 | -$78.55M derived: sum of 3 quarters · filed 2024-08-06 | -$3.08M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$34.94M 10-Q · filed 2024-05-07 | -$66.60M derived: sum of 2 quarters · filed 2024-05-07 | $8.86M derived: sum of 3 quarters · filed 2024-05-07 | -$29.23M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$31.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $43.80M derived: sum of 2 quarters · filed 2024-02-28 | $5.71M derived: sum of 3 quarters · filed 2024-02-28 | -$29.05M 10-K · filed 2024-02-28 |
| 2022-09-30 | $75.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $37.37M derived: sum of 2 quarters · filed 2023-11-09 | $2.61M 10-Q · filed 2023-11-09 | -$25.68M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$38.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$72.85M 10-Q · filed 2023-08-09 | -$101.14M derived: sum of 3 quarters · filed 2023-08-09 | -$132.03M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$34.76M 10-Q · filed 2023-05-09 | -$63.05M derived: sum of 2 quarters · filed 2023-05-09 | -$93.94M derived: sum of 3 quarters · filed 2023-05-09 | -$120.25M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$28.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$59.18M derived: sum of 2 quarters · filed 2023-02-28 | -$85.49M derived: sum of 3 quarters · filed 2023-02-28 | -$106.91M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$30.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$57.20M derived: sum of 2 quarters · filed 2022-11-09 | -$78.62M 10-Q · filed 2022-11-09 | -$93.88M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$26.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$47.73M 10-Q · filed 2022-08-04 | -$62.99M derived: sum of 3 quarters · filed 2022-08-04 | -$76.74M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$21.42M 10-Q · filed 2022-05-05 | -$36.68M derived: sum of 2 quarters · filed 2022-05-05 | -$50.43M derived: sum of 3 quarters · filed 2022-05-05 | -$62.23M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$15.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$29.01M derived: sum of 2 quarters · filed 2022-03-01 | -$40.82M derived: sum of 3 quarters · filed 2022-03-01 | -$53.42M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$13.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$25.55M derived: sum of 2 quarters · filed 2021-11-10 | -$38.15M 10-Q · filed 2021-11-10 | -$46.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$24.40M 10-Q · filed 2021-08-12 | -$32.73M derived: sum of 3 quarters · filed 2022-03-01 | -$40.42M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$12.60M 10-Q · filed 2021-05-13 | -$20.93M derived: sum of 2 quarters · filed 2022-03-01 | -$28.62M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$16.02M derived: sum of 2 quarters · filed 2022-03-01 | -$27.22M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$7.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$18.89M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$11.20M 10-Q · filed 2020-08-13 |